Series date:
01/01/2017 - 12:30pm to 12/31/2017 - 1:30pm
Where did the idea for the course originate?:
Florida
| Session | Date |
|---|---|
| Cutaneous T-Cell Lymphoma | 01/06/2017 - 12:30pm to 1:30pm |
| Myelofibrosis: Transplantation in the Era of JAK Inhibitor | 01/13/2017 - 12:30pm to 1:30pm |
| Colorectal Cancer in Alaska Natives: An Example of Mayo's Commitment to Overcome Disparities | 01/20/2017 - 12:30pm to 1:30pm |
| ASH 2016 Updates: Multiple Myeloma | 02/17/2017 - 12:30pm to 1:30pm |
| Acute Graft v. Host Disease: Risk Factors, Outcomes, and Predicative Markers | 04/07/2017 - 12:30pm to 1:30pm |
| Is myeloablative dose intensity required in allogeneic HCT for lymphomas? | 04/14/2017 - 12:30pm to 1:30pm |
| Front Line Treatment of DLBCL - Time for Individualized Therapy | 04/21/2017 - 12:30pm to 1:30pm |
| “Immune Thrombocytopenia (ITP): Does Sequence of Treatment Matter?” | 05/05/2017 - 12:30pm to 1:30pm |
| Updates in Cholangiocarcinoma | 06/09/2017 - 12:30pm to 1:30pm |
| “Non- Small Cell Lung Cancer: Treatment Trends and Biomarkers of Immunotherapy Response” | 06/16/2017 - 12:30pm to 1:30pm |